Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
出版年份 2020 全文链接
标题
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
作者
关键词
-
出版物
Acta Neuropathologica Communications
Volume 8, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-18
DOI
10.1186/s40478-020-00917-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples
- (2019) Michael L. Miller et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Defining EGFR amplification status for clinical trial inclusion
- (2019) Pim J French et al. NEURO-ONCOLOGY
- Comparison of kNN and k-means optimization methods of reference set selection for improved CNV callers performance
- (2019) Wiktor Kuśmirek et al. BMC BIOINFORMATICS
- A Simple, Universal, and Cost-Efficient Digital PCR Method for the Targeted Analysis of Copy Number Variations
- (2019) Kévin Cassinari et al. CLINICAL CHEMISTRY
- Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
- (2019) Andrew B. Lassman et al. JOURNAL OF NEURO-ONCOLOGY
- Antitumor Activity of a Binary EGFR/DNA Targeting Strategy Overcomes Resistance of Glioblastoma Stem cells to Temozolomide
- (2019) Zeinab Sharifi et al. CLINICAL CANCER RESEARCH
- Defining the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression profiling assay (RT-MLPA)
- (2019) Fanny Drieux et al. HAEMATOLOGICA
- INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma
- (2019) Martin van den Bent et al. NEURO-ONCOLOGY
- Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development
- (2018) Tomoyuki Koga et al. NEURO-ONCOLOGY
- Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
- (2018) Zhenyi An et al. ONCOGENE
- Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
- (2018) Damian Stichel et al. ACTA NEUROPATHOLOGICA
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
- (2018) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Beyond sequence variation: assessment of copy number variation in adult glioblastoma through targeted tumor somatic profiling
- (2018) Samantha N. McNulty et al. HUMAN PATHOLOGY
- Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier
- (2017) Victor Bobée et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma
- (2017) Nicolas Piton et al. LABORATORY INVESTIGATION
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
- (2017) Juan Manuel Sepúlveda-Sánchez et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
- (2016) Angela Zacher et al. BRAIN PATHOLOGY
- Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data
- (2015) Catherine Grasso et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma
- (2015) Shakti H. Ramkissoon et al. NEURO-ONCOLOGY
- Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data
- (2014) Valentina Boeva et al. BIOINFORMATICS
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
- (2014) P. Y. Wen et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
- (2010) Joon H. Uhm et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now